Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-18-011951

Exec VP, Comm Optns acquired 2,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BOYER ANDREW S Exec VP, Comm Optns 2018-05-04 Grant or award +2,000 2,000 D
Derivatives
BOYER ANDREW S Exec VP, Comm Optns 2018-05-07 Grant or award · Stock Option +272,480 272,480 D
BOYER ANDREW S Exec VP, Comm Optns 2018-05-07 Grant or award · Restricted Stock Units +66,622 66,622 D
Loading xslF345X03/doc4.xml…